These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7962474)

  • 61. Effect of single-dose, early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey.
    Ghosh D; Sengupta J; Hendrickx AG
    Hum Reprod; 1996 Sep; 11(9):2026-35. PubMed ID: 8921085
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys.
    Neulen J; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1074-5. PubMed ID: 2401709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mammary gland and endometrial effects of testosterone in combination with oral estradiol and progesterone.
    Wood CE; Lees CJ; Cline JM
    Menopause; 2009; 16(3):466-76. PubMed ID: 19265727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
    Ruiz A; Aguilar R; Tébar AM; Gaytán F; Sánchez-Criado JE
    Biol Reprod; 1996 Dec; 55(6):1284-91. PubMed ID: 8949885
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway.
    Turgeon JL; Waring DW
    Mol Endocrinol; 1994 Jul; 8(7):860-9. PubMed ID: 7984148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low dose RU486 prevents progesterone antagonism on uterine growth and concomitant type II oestradiol binding induction by oestradiol in rats.
    Garai J; Vértes M; Kovàcs S
    J Recept Res; 1990; 10(3-4):169-89. PubMed ID: 2262937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor.
    Brenner RM; Slayden OD; Critchley HO
    Reproduction; 2002 Aug; 124(2):167-72. PubMed ID: 12141929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.
    Dockery P; Ismail RM; Li TC; Warren MA; Cooke ID
    Hum Reprod; 1997 Aug; 12(8):1778-84. PubMed ID: 9308811
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.
    McDonnell DP; Goldman ME
    J Biol Chem; 1994 Apr; 269(16):11945-9. PubMed ID: 8163495
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pre-clinical and clinical treatment of breast cancer with antiprogestins.
    Klijn JG; Setyono-Han B; Sander HJ; Lamberts SW; de Jong FH; Deckers GH; Foekens JA
    Hum Reprod; 1994 Jun; 9 Suppl 1():181-9. PubMed ID: 7962463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of progestin antagonists, glucocorticoids and estrogen on progesterone-induced protein secreted by rabbit endometrial stromal cells in culture.
    Bigsby RM; Everett LM
    J Steroid Biochem Mol Biol; 1991 Jul; 39(1):27-32. PubMed ID: 2069862
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of the antiprogestin RU486 on progesterone-dependent uterine development and bioassay of progestational activity in estrogen-primed immature female dogs.
    Concannon PW; Dillingham L; Spitz IM
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):389-98. PubMed ID: 3394473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice.
    Zhou YF; Matsuda M; Mori T; Sakamoto S; Mitamura T
    Life Sci; 2000 Oct; 67(22):2713-20. PubMed ID: 11105987
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RU486-induced growth inhibition of human endometrial cells.
    Murphy AA; Zhou MH; Malkapuram S; Santanam N; Parthasarathy S; Sidell N
    Fertil Steril; 2000 Nov; 74(5):1014-9. PubMed ID: 11056251
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The progesterone antagonist, RU486 does not affect basal or estrogen-stimulated cancellous bone formation in the rat.
    Abe T; Chow JW; Lean JM; Chambers TJ
    Bone Miner; 1992 Dec; 19(3):225-33. PubMed ID: 1472894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progesterone in vitro stimulates secretion of a specific protein by ovine epithelial endometrial cells.
    Salamonsen LA; Healy DL; Findlay JK
    J Steroid Biochem; 1987 Sep; 28(3):285-8. PubMed ID: 3657150
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antifertility potential of 2-[piperdinoethoxyphenyl]-3-[4- methoxyphenyl]-2H benzopyran: a potent anti-oestrogenic compound in rats.
    Singh R
    J Reprod Fertil; 1996 Jan; 106(1):49-53. PubMed ID: 8667345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiprogestin action on the endometrium.
    Nieman L
    Ann N Y Acad Sci; 1997 Sep; 828():103-7. PubMed ID: 9329827
    [No Abstract]   [Full Text] [Related]  

  • 79. Sex hormone dose escalation for treating abnormal sleep in ovariectomized rats: in vitro GABA synthesis in sleep-related brain areas.
    Carrasco-Nuñes N; Romano M; Cabeza M
    Can J Physiol Pharmacol; 2023 Oct; 101(10):529-538. PubMed ID: 37364372
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Site of action for the estradiol-induced luteinizing hormone surge in farm animals and primates.
    Kesner JS
    Domest Anim Endocrinol; 1988 Oct; 5(4):265-81. PubMed ID: 3073037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.